Davarpanah Nicole Negar 4
4 · Cidara Therapeutics, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Davarpanah Nicole Negar
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2025-12-10$219.60/sh−10,332$2,268,907→ 21,286 total
Footnotes (2)
- [F1]Shares withheld for taxes on RSU vesting.
- [F2]Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP) on November 20, 2025.